Inhibition of expression of beta-lactamase using esters of fatty acid alcohols

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5466685
SERIAL NO

08061222

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A class of chemical compounds comprising fatty acid ester derivatives used to inhibit beta-lactamase production by infectious bacteria. These inhibitors have been found to retard the resistance of certain strains of bacteria to beta-lactam antibiotics, such as penicillin, by interfering with the transcription of the beta-lactamase gene and precluding expression of beta-lactamase. In accordance therewith, these inhibitors permit effective treatment of infections of otherwise resistive bacteria with antibiotics.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEYOFFICE OF PATENTS AND LICENSING ONE WORLD'S FAIR DRIVE SUITE 2100 SOMERSET NJ 08873

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Brown-Skrobot, Susan Hamilton, NJ 7 95
Novick, Richard P New York, NY 8 50
Projan, Steven J New York, NY 6 114

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation